“Per quinque gradus ad victoriam” Latin

Through five strategic steps to victory

WHO WE ARE

A UAE-founded consulting firm exclusively serving the healthcare, pharmaceutical, and broader life sciences sector, focusing on high-complexity initiatives through three core service lines: strategy consulting, strategic projects delivery, and innovation & Artificial Intelligence research & consultancy.

OUR MISSION

We are passionate about delivering comprehensive, tailored, and high-impact expertise that accelerates healthcare and pharmaceutical innovation and drives transformative healthcare solutions across the UAE and Middle East, as well as advancing patient access to breakthrough treatments in
underserved global markets.

OUR SERVICES

/// STRATEGY

/// STRATEGIC PROJECTS

/// AI RESEARCH & CONSULTANCY

Early launch & launch excellence
Portfolio management
UAE and Middle East market-entry strategy solutions for overseas organisations expanding
their business to the region
Strategies enabling innovative technologies requiring a policy-shaping approach and/or public-
private partnerships
Expert support translating pharma and healthcare complexities and regulatory compliance
requirements into actionable strategies for IT, Tech, PR, and other service providers, supporting healthcare & pharma sector clients lacking in-house industry expertise

Business transformation
Business model redesign
Comprehensive operational excellence programs
M&A integration
New innovative payment and access models
Integrated care & patient-centred solutions

Healthcare & pharmaceutical industry-tailored AI strategies, integration, and transformation
AI research advancing patient access to breakthrough treatments in underserved international markets

OUR TEAM

///

Our team brings over 40 years of combined experience at Fortune 500 and Fortune Global 500 Big Pharma organisations, where we have successfully served 70+ markets across Europe, the Middle East & Africa (MEA), USA, CIS, and JAPAC.

///

Our multidisciplinary expertise spans strategy, business development, transformation, regulatory compliance, AI governance and enabling emerging and innovative therapies – from solid forms, medical devices, and technology to cell & gene and radio-nucleotide treatments – across key therapeutic areas including oncology, rare diseases, cardiology, immunology, neurology, metabolic, respiratory, transplantology, dermatology, ophthalmology, and medical aesthetics.

///

This broad and deep sector expertise, coupled with comprehensive knowledge of healthcare systems, regulations, market dynamics, regulatory frameworks, specifics of industry commercial, manufacturing, hospital, and clinic operations, healthcare service delivery models, and patient pathways, enables us to deliver world-class solutions tailored for complex, high-impact healthcare challenges.